The eCOA market offers opportunities driven by the pharmaceutical shift to patient-centric research and increased decentralized trials requiring robust digital tools for data integrity and efficiency.

Early detection of safety liabilities of new therapies is a critical biopharmaceutical challenge. Addressing this challenge could significantly advance drug discovery. Advanced human cell models, ...

HistoIndex, a pioneer in AI-driven digital pathology solutions for chronic liver disease, has announced a strategic partnership with Houston Research Institute (HRI). HRI is ...